Cross Shore Discovery Fund | |||||||||||||
Schedule of Investments (Unaudited) | |||||||||||||
December 31, 2023 | |||||||||||||
Next | |||||||||||||
Initial | Available | ||||||||||||
% of | Acquisition | Redemption | Redemption | ||||||||||
Portfolio Funds* | Net Assets | Cost(1) | Fair Value | Date | Frequency(2) | Date | |||||||
Long/Short Generalist: | |||||||||||||
Atika Offshore Fund, Ltd., Class A, Series 1 | 4.5% | $ 677,447 | $ 1,445,365 | 1/2/2015 | Quarterly | 3/31/2024 | |||||||
EVR Offshore Partners Fund, Ltd., Class B, Series 1121 | 4.5% | 1,312,500 | 1,444,943 | 11/1/2021 | Quarterly | 3/31/2024 | (3) | ||||||
Hawk Ridge Partners Offshore, Ltd., Class A, Initial Series | 9.0% | 1,600,000 | 2,904,335 | 2/1/2018 | Quarterly | 3/31/2024 | |||||||
Hill City Capital Offshore Fund Ltd., Class A, Series 14 | 4.8% | 1,312,500 | 1,555,529 | 11/1/2021 | Quarterly | 3/31/2024 | (3) | ||||||
TCIM Offshore Fund Ltd., Class A-33, Series 2019-12 | 8.2% | 1,756,890 | 2,635,809 | 12/1/2019 | Monthly | 1/31/2024 | |||||||
Wolf Hill Offshore Fund, Ltd., Class A-OS, Series 2020-08 | 5.0% | 1,300,000 | 1,601,980 | 7/1/2021 | Quarterly | 3/31/2024 | |||||||
Total Long/Short Generalist | 36.0% | 7,959,337 | 11,587,961 | ||||||||||
Long/Short Sector: | |||||||||||||
Energy | |||||||||||||
Encompass Capital Fund Offshore Ltd., Class A, Series 1 | 10.6% | 1,803,039 | 3,399,717 | 1/1/2020 | Quarterly | 3/31/2024 | |||||||
Healthcare, Biotechnology | |||||||||||||
Avoro Life Sciences Offshore Fund Ltd., Class A-1 | 13.4% | 1,069,545 | 4,325,706 | 5/1/2017 | Quarterly | 3/31/2024 | |||||||
Biomedical Offshore Value Fund, Ltd., Class I, Series 200199-1 | 10.7% | 2,100,000 | 3,448,585 | 1/1/2019 | Quarterly | 3/31/2024 | |||||||
Total Healthcare, Biotechnology | 24.1% | 3,169,545 | 7,774,291 | ||||||||||
Technology, Media and Telecommunications | |||||||||||||
Atreides Foundation Fund, Ltd., Founders Class, Series F-2 | 5.9% | 1,189,143 | 1,878,089 | 5/15/2019 | Quarterly | 3/31/2024 | (3) | ||||||
Total Long/Short Sector | 40.6% | 6,161,727 | 13,052,097 | ||||||||||
Total Investments In Portfolio Funds | 76.6% | $ 14,121,064 | $ 24,640,058 | ||||||||||
% of | |||||||||||||
Money Market Funds | Net Assets | Cost | Fair Value | Shares | |||||||||
Federated Hermes Institutional Prime Obligations Fund, | |||||||||||||
Institutional Class, 5.45%(4) | 11.6% | $ 3,747,300 | $ 3,749,602 | 3,746,604 | |||||||||
Total Investments | 88.2% | $ 17,868,364 | $ 28,389,660 | ||||||||||
Other Assets in Excess of Liabilities | 11.8% | $ 3,800,447 | |||||||||||
Net Assets | 100.0% | $ 32,190,107 | |||||||||||
* Non-income producing security. | |||||||||||||
(1) There were no unfunded capital commitments as of December 31, 2023. | |||||||||||||
(2) Certain redemptions may be subject to various restrictions and limitations such as redemption penalties on investments liquidated within a certain period subsequent to investment (e.g., a soft or hard lock-up), investor-level gates and/or Portfolio Fund-level gates. Redemption notice periods range from 30 to 120 days. | |||||||||||||
(3) Subject to 25% investor level quarterly gate. | |||||||||||||
(4) Rate disclosed is the seven day effective yield as of December 31, 2023. | |||||||||||||